Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohamad A Hussein

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Expert Opinion on Pharmacotherapy|March 25, 2006
Pharmacotherapy of multiple myelomaMohamad A Hussein
Cancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Trials of arsenic trioxide in multiple myelomaMohamad A Hussein
Thrombosis and Haemostasis|May 30, 2006
Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinationsMohamad A Hussein
Seminars in Hematology|March 16, 2005
New treatment strategies for multiple myelomaMohamad A Hussein
Oncology (Williston Park, N.Y.)|November 6, 2004
Salvage therapy options for myeloma patientsMohamad A Hussein,
The Oncologist|December 13, 2003
Modifications to therapy for multiple myeloma: pegylated liposomal Doxorubicin in combination with vincristine, reduced-dose dexamethasone, and thalidomideMohamad A Hussein
The Oncologist|April 19, 2002
Nontraditional cytotoxic therapies for relapsed/refractory multiple myelomaMohamad A Hussein
Seminars in Hematology|December 14, 2005
Lenalidomide: patient management strategiesMohamad A Hussein
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Multiple myeloma: most common end-organ damage and managementMohamad A Hussein
Expert Review of Anticancer Therapy|March 11, 2005
Thalidomide: present and future in multiple myelomaMohamad A Hussein
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Expert Opinion on Pharmacotherapy|March 25, 2006
Pharmacotherapy of multiple myelomaMohamad A Hussein
Cancer Control : Journal of the Moffitt Cancer Center|October 29, 2003
Trials of arsenic trioxide in multiple myelomaMohamad A Hussein
Thrombosis and Haemostasis|May 30, 2006
Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinationsMohamad A Hussein
Seminars in Hematology|March 16, 2005
New treatment strategies for multiple myelomaMohamad A Hussein
Oncology (Williston Park, N.Y.)|November 6, 2004
Salvage therapy options for myeloma patientsMohamad A Hussein,
The Oncologist|December 13, 2003
Modifications to therapy for multiple myeloma: pegylated liposomal Doxorubicin in combination with vincristine, reduced-dose dexamethasone, and thalidomideMohamad A Hussein
The Oncologist|April 19, 2002
Nontraditional cytotoxic therapies for relapsed/refractory multiple myelomaMohamad A Hussein
Seminars in Hematology|December 14, 2005
Lenalidomide: patient management strategiesMohamad A Hussein
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2007
Multiple myeloma: most common end-organ damage and managementMohamad A Hussein
Expert Review of Anticancer Therapy|March 11, 2005
Thalidomide: present and future in multiple myelomaMohamad A Hussein
Pageof 6